Skip to main content
. 2022 Jul 5;14(28):31525–31540. doi: 10.1021/acsami.2c02741

Figure 2.

Figure 2

(A) Schematic representation of a possible hypericin β-cyclodextrin inclusion mode.46 (B) Phase solubility diagram of the hypericin β-cyclodextrin complex system at 37 °C. (C) UV–vis spectra of hypericin β-cyclodextrin with different concentrations of β-cyclodextrin % (w/v) in aqueous solution (pH 7.4, 25 °C) (n = 3).